UK and EU agree on phased process for Northern Ireland medicines regulation
Industry bodies respond to Specialised Committee outcome
Read More
Tag: Northern Ireland
New research highlights Northern Ireland’s ‘thriving’ life sciences sector
Pharmaceutical and life sciences industries are growing in importance across country
Read More
Lyrica reclassified after being linked to 33 deaths
The drug was linked to 33 deaths in in Northern Ireland in 2018, a jump from just eight in 2017.
Read More
DH moves to ensure equal access to cancer drugs in NI
The Department of Health in Northern Ireland has unveiled plans to boost access to innovative new medicines for cancers and other conditions.
Read More
Inequalities in Northern Ireland putting child health at risk
The growing divide between rich and poor is risking the health of children in Northern Ireland, warns the Royal College of Paediatrics and Child Health (RCPCH).
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
